IOCN and UK SACT Board Joint Letter to NHS England
News posted: 24.07.25 Post by:
Time to read: ~ minutes, give or take.
The IOCN and UKSACT Board have written to NHS England, to raise concerns about access to funding for immunosuppressant medicines used to manage the adverse effects of immune- checkpoint inhibitors (ICIs).
We have proposed a working collaboration with NHS England to create an appropriate standardised framework within which to manage access to immunosuppressive treatments, adress inequality and optimise patient outcomes.